PacSun Skins Its Knees

Recs

4

Disney Buys Marvel!

...And David Gardner called it. He's up 1,334%! See what David's recommending that you buy NEXT!

Click here now to find out!

That $293 million buyout offer for Pacific Sunwear (Nasdaq: PSUN) from Adrenalina is looking pretty good these days, huh?

Well, maybe not, considering the three-store chain has scant financing to put the deal together, let alone the dubious history of its CEO. More to the point, though, PacSun was able to narrow its loss for the quarter even as sales continued to take it on the chin. Add in an analyst saying the surf-and-skate crowd retailer can probably survive as a going concern and presto! You've got a viable investment again.

The upheaval that wrenched the markets in September and October was unprecedented in recent years. While the financial markets tottered, consumers basically shut down their spending. Was that the cause of or a response to the drama? I tend to lean more toward the latter. If you unsure whether Western civilization is on the precipice of collapse, that Element t-shirt your teen is eyeing doesn't quite seem so important.

The waters aren't calm yet, but with the Christmas season approaching, I think corporate management is taking a prudently cautious outlook. PacSun, for example, is forecasting high single-digit declines in same-store sales. Abercrombie & Fitch (NYSE: ANF) is expecting a 26% drop in comps, making it the worst holiday season in 18 years. And Aeropostale (NYSE: ARO), which has been a relative beacon of hope, will be coming up against difficult comps numbers, which has some analysts thinking it's poised for a fall.

Yet I like PacSun here for a number of reasons. While some competitors, like Volcom (Nasdaq: VLCM), look insanely cheap, and others like Gap (NYSE: GPS) are far from compelling, on a number of metrics PacSun also seems like a steal. With shares trading near historical lows, it's valued at a fraction of its quarterly sales, it trades at just a fourth of its book value, and the retailer's enterprise value is just 1.4 times EBITDA. Management is also wisely reining in new capital expenditures and has a fairly clean balance sheet.

Until the economy began to tank in earnest in 2007, PacSun had been able to grow revenues at a five-year compounded annual growth rate of 18% while profits grew at 26%. Admittedly, since the close of 2006, they've pretty much been shredded, and getting out of the current economic malaise is obviously the first priority. Once achieved, however, a leaner PacSun ought to be able to return to its profit-making ways.

When a stock has lost 90% of its value over much of the past year, it's difficult to believe the investment thesis can still hold. As a shareholder, I've ridden this one all the way down, but have not considered selling; this appears to be a retail story that can still ride the next wave.

Related Foolishness:

Closed for 15 months – opening 10 days only! Get notified ahead of time as our expert portfolio manager invests $1 MILLION in the best opportunities from across The Motley Fool’s premium investment services. This is the first open since August 2008, by invitation only. Enter email below.

Pacific Sunwear is a Motley Fool Hidden Gems Pay Dirt pick. Volcom is a Motley Fool Hidden Gems recommendation. Gap is a Motley Fool Inside Value selection. Pacific Sunwear, Gap, and American Eagle Outfitters are Motley Fool Stock Advisor selections. The Fool owns shares of American Eagle Outfitters. Try any of our Foolish newsletters today, free for 30 days.

Fool contributor Rich Duprey owns shares of PacSun but does not have a financial position in any of the other stocks mentioned in this article. You can see his holdings here. The Motley Fool has a disclosure policy.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On November 20, 2008, at 12:56 PM, Slipswitch wrote:

    The problem is that PSUN may be viable as an enterprise, but maybe not in a public market. If they are acquired those who followed the MF Stock Advisor recommendation to buy but not too sell will have lost about 90% of their investment.

    I'm just glad I cut my losses on VLCM, another recommendation.

Add your comment.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 779801, ~/Articles/ArticleHandler.aspx, 11/10/2009 7:59:47 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Health-Care Reform: A Tale of Two Chambers

Related Tickers

11/9/2009 4:01 PM
ANF $37.59 Up +2.58 +7.37%
Abercrombie & Fitc… CAPS Rating: **
ARO $33.88 Up +0.18 +0.53%
Aeropostale, Inc. CAPS Rating: **
GPS $22.92 Down -0.11 -0.48%
The Gap, Inc. CAPS Rating: **
PSUN $4.95 Down -0.14 -2.75%
Pacific Sunwear of… CAPS Rating: **
VLCM $16.99 Up +0.46 +2.78%
Volcom, Inc. CAPS Rating: ****

Community: Investing Wiki

Term Of The Hour

Biotechnology: Biotechnology uses biological processes to solve problems in such areas as health and medicine, agriculture and manufacturing.

Want to learn more or edit this definition?
Click here to read more!